Cited by 233Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and TreatmentsIgG4-Related and Inflammatory Diseases

Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history

Open access
Deneau, Mark, Jensen, Kyle M., Holmen, John, Williams, Marc S., Book, Linda S., Guthery, Stephen L.·2013·Hepatology

Abstract

The epidemiology and natural history of pediatric primary sclerosing cholangitis (PSC), autoimmune sclerosing cholangitis (ASC), and autoimmune hepatitis (AIH) are not well characterized. Using multiple, overlapping search strategies followed by a detailed records review, we identified all cases of pediatric PSC, ASC, AIH, and inflammatory bowel disease (IBD) in a geographically isolated region of the United States. We identified 607 cases of IBD, 29 cases of PSC, 12 cases of ASC, and 44 cases of AIH. The mean age at diagnosis was 13.0 years for PSC, 11.3 years for ASC, and 9.8 years for AIH. The incidence and prevalence of PSC, ASC, and AIH were 0.2 and 1.5 cases, 0.1 and 0.6 cases, and 0.4 and 3.0 cases per 100,000 children, respectively. The mean duration of follow-up was 5.9 years. The probability of developing complicated liver disease within 5 years of the diagnosis of liver disease was 37% [95% confidence interval (CI) = 21%-58%] for PSC, 25% (95% CI = 7%-70%) for ASC, and 15% (95% CI = 7%-33%) for AIH. The 5-year survival rates with the native liver were 78% (95% CI = 54%-91%) for PSC, 90% (95% CI = 47%-99%) for ASC, and 87% (95% CI = 71%-95%) for AIH. Cholangiocarcinoma developed in 2 of the 29 PSC patients (6.9%). PSC occurred in 9.9% of patients with ulcerative colitis (UC) and in 0.6% of patients with Crohn's disease (CD). ASC occurred in 2.3% of UC patients and 0.9% of CD patients. AIH occurred in 0.4% of UC patients and in 0.3% of CD patients. Liver disease occurred in 39 of 607 IBD patients (6.4%) overall. Conclusion : Immune-mediated liver diseases are important sources of morbidity in children. Using a population-based design, this study quantifies the burden and natural history of immune-mediated liver disease in children. (Hepatology 2013;58:1392–1400)

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.26454

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A population-based multicentre study in the USA estimated the prevalence of PSC as 0.2/10,000 children compared to up to 16/100,000 in adults.

    “A population-based multicentre study in the USA estimated the prevalence of PSC as 0.2/10,000 children compared to up to 16/100,000 in adults.424”

    From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [424]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Jimenez-Rivera C, Graitson S, Critch J, Rashid M, Ling S, Ng V, et al. Incidence and characteristics of autoimmune hepatitis in children and adolescents in Canada: a preliminary report of the Canadian Pediatric Hepatology Research Group [abstract]. HEPATOLOGY 2012;54:138A.

Cited by

Sorted by citations

Authors
Deneau, M., Jensen, K. M., Holmen, J., Williams, M. S., Book, L. S., & Guthery, S. L.
Affiliations
  • University of Utah (US)
  • Intermountain Healthcare (US)
  • Geisinger Health System (US)
Corresponding author
Deneau, Mark
Venue
Hepatology
Published
2013-10
Volume
58
Issue
4
Pages
1392-1400
ISSN
0270-9139 (ISSN-L)
OpenAlex
W1507163675
Cited by
233
References
45
Citations by year
2026: 15 · 2025: 14 · 2024: 13 · 2023: 16 · 2022: 20 · 2021: 26 · 2020: 14 · 2019: 28 · 2018: 20 · 2017: 22 · 2016: 16 · 2015: 16 · 2014: 10 · 2013: 1 · 2012: 1
FWCI
8.94
Type
journal article
Language
en
Open access
Locations
  • Hepatology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (UL1TR000077, UL1TR000105)
  • National Center for Research Resources (UL1RR025764)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
  • Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
Keywords
primary sclerosing cholangitis, autoimmune sclerosing cholangitis, autoimmune hepatitis, pediatric liver disease, inflammatory bowel disease, ulcerative colitis, Crohn's disease, cholangiocarcinoma, incidence and prevalence, natural history (disease), survival, immune-mediated liver disease, disease overlap, epidemiology
MeSH terms
Adolescent, Autoimmune Diseases, Child, Child, Preschool, Female, Humans, Infant, Male, Retrospective Studies, Utah, Cholangitis, Sclerosing, Prevalence, Survival Rate, Hepatitis, Autoimmune

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review